Mesenchymal stem cell therapy in amyotrophic lateral sclerosis (ALS) patients: A comprehensive review of disease information and future perspectives

Amyotrophic lateral sclerosis (ALS) is a rare deadly progressive neurological disease that primarily affects the upper and lower motor neurons with an annual incidence rate of 0.6 to 3.8 per 100,000 people. Weakening and gradual atrophy of the voluntary muscles are the first signs of the disease ons...

Descripción completa

Detalles Bibliográficos
Autores principales: Najafi, Shahrzad, Najafi, Parizad, Kaffash Farkhad, Najmeh, Hosseini Torshizi, Ghazal, Assaran Darban, Reza, Boroumand, Amir Reza, Sahab-Negah, Sajad, Khodadoust, Mohammad Ali, Tavakol-Afshari, Jalil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mashhad University of Medical Sciences 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329242/
https://www.ncbi.nlm.nih.gov/pubmed/37427325
http://dx.doi.org/10.22038/IJBMS.2023.66364.14572

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329242/
https://www.ncbi.nlm.nih.gov/pubmed/37427325
http://dx.doi.org/10.22038/IJBMS.2023.66364.14572

Ejemplares similares